Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes

Biochimie

Volumn 92, Issue 2, 2010, Pages 204-215

  Campo, Giuseppe M ^a   Avenoso, Angela ^a   Campo, Salvatore ^a   D'Ascola, Angela ^a   Nastasi, Giancarlo ^a   Calatroni, Alberto ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chondrocytes; Cytokines; Hyaluronan; Lipopolysaccharides; NF kB factor

Indexed keywords

COLLAGENASE 3; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CHONDROPATHY; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN FAMILY; PROTEIN TARGETING; RECEPTOR UPREGULATION;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CELLS, CULTURED; CHONDROCYTES; HYALURONIC ACID; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74249106459     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.10.006     Document Type: Article

References (43)

1. Martel-Pelletier J., Boileau C., Pelletier J.P., and Roughley P.J. Cartilage in normal and osteoarthritis conditions, best pract. Res. Clin. Rheumatol. 22 (2008) 351-384
2. Gaston J.S. Cytokines in arthritis - the 'big numbers' move centre stage. Rheumatology (Oxford) 47 (2008) 8-12
3. Murphy G., and Nagase H. Progress in matrix metalloproteinase research. Mol. Aspects Med. 29 (2008) 290-308
4. Takaishi H., Kimura T., Dalal S., Okada Y., and D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 9 (2008) 47-54
5. McNulty A.L., Moutos F.T., Weinberg J.B., and Guilak F. Enhanced integrative repair of the porcine meniscus in vitro by inhibition of interleukin-1 or tumor necrosis factor alpha. Arthritis Rheum. 56 (2007) 3033-3042
6. Finckh A., and Gabay C. At the horizon of innovative therapy in rheumatology: new biologic agents. Curr. Opin. Rheumatol. 20 (2008) 269-275
7. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., and Hoebe K. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
8. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
9. Hughes A.L., and Piontkivska H. Functional diversification of the toll-like receptor gene family. Immunogenetics 60 (2008) 249-256
10. O'Neill L.A. How toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
11. Xie P., Kraus Z.J., Stunz L.L., and Bishop G.A. Roles of TRAF molecules in B lymphocyte function. Cytokine Growth Factor Rev. 19 (2008) 199-207
12. Loniewski K.J., Patial S., and Parameswaran N. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Mol. Immunol. 44 (2007) 3715-3723
13. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242 (1997) 27-33
14. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Purè E., Henson P.M., and Noble P.W. Resolution of lung inflammation by CD44. Science 296 (2002) 155-158
15. Nobel P.W., McKee C.M., Cowman M., and Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med. 183 (1996) 2373-2378
16. Termeer C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., and Simon J.C. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165 (2000) 1863-1870
17. Rescigno M., Granucci F., Citterio S., Foti M., and Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol. Today 20 (1999) 200-203
18. Chen T., Guo J., Han C., Yang M., and Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J. Immunol. 182 (2009) 1449-1459
19. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., and Noble P.W. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat. Med. 11 (2005) 1173-1179
20. Cantor J.O., and Nadkarni P.P. Hyaluronan: the Jekyll and Hyde molecule. Inflamm. Allergy Drug Targets 5 (2006) 257-260
21. Stern R., Asari A.A., and Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 85 (2006) 699-715
22. Jiang D., Liang J., and Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23 (2007) 435-461
23. Yamawaki H., Hirorhata S., Miyoshi T., Takahashi K., Ogawa H., Shinohata R., Demircan K., Kusachi S., Yamamoto K., and Ninomiya Y. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19 (2009) 83-92
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
25. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
26. Voelcker V., Gebhardt C., Averbeck M., Saalbach A., Wolf V., Weih F., Sleeman J., Anderegg U., and Simon J. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp. Dermatol. 17 (2008) 100-107
27. Schulze-Tanzil G. Activation and dedifferentiation of chondrocytes: implications in cartilage injury and repair. Ann. Anat. 191 (2009) 325-338
28. Rosa S.C., Judas F., Lopes M.C., and Mendes A.F. Nitric oxide synthase isoforms and NF-kappaB activity in normal and osteoarthritic human chondrocytes: regulation by inducible nitric oxide. Nitric Oxide 19 (2008) 276-283
29. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
30. Oyama J., Blais Jr. C., Liu X., Pu M., Kobzik L., Kelly R.A., and Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004) 784-789
31. Tsung A., Hoffman R.A., Izuishi K., Critchlow N.D., Nakao A., Chan M.H., Lotze M.T., Geller D.A., and Billiar T.R. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J. Immunol. 175 (2005) 7661-7668
32. Abdollahi-Roodsaz S., Joosten L.A., Roelofs M.F., Radstake T.R., Matera G., Popa C., van der Meer J.W., Netea M.G., and van den Berg W.B. Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56 (2007) 2957-2967
33. van den Berg W.B., van Lent P.L., Joosten L.A., Abdollahi-Roodsaz S., and Koenders M.I. Amplifying elements of arthritis and joint destruction. Ann. Rheum. Dis. 66 Suppl. 3 (2007) 45-48
34. Yates E.A., Terry C.J., Rees C., Rudd T.R., Duchesne L., Skidmore M.A., Lévy R., Thanh N.T., Nichols R.J., Clarke D.T., and Fernig D.G. Protein-GAG interactions: new surface-based techniques, spectroscopies and nanotechnology probes. Biochem. Soc. Trans. 34 (2006) 427-430
35. Scheibner K.A., Lutz M.A., Boodoo S., and Fenton M.J. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177 (2006) 1272-1281
36. Adair-Kirk T.L., and Senior R.M. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40 (2008) 1101-1110
37. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., Cavicchini S., Balsari A., and Rumio C. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J. Immunol. 181 (2008) 2103-2110
38. Eberlein M., Scheibner K.A., Black K.E., Collins S.L., Chan-Li Y., Powell J.D., and Horton M.R. Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J. Inflamm. 5 (2008) 5-20
39. Shi Y., Evans J.E., and Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521
40. Lohr M., Hummel F., Martus P., Cidlinsky K., Kröger J.C., Hahn E.G., Oesterling C., Emmrich J., Schuppan D., and Liebe S. Serum levels of extracellular matrix in acute pancreatitis. Hepatogastroenterology 46 (1999) 3263-3270
41. Sasamura H., Kitamura Y., Nakamura M., Ryuzaki M., and Saruta T. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension. Clin. Exp. Hypertens. 28 (2006) 511-520
42. Kong S.Y., Stabler T.V., Criscione L.G., Elliott A.L., Jordan J.M., and Kraus V.B. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 54 (2006) 2496-2504
43. Farkkila M., Rautiainen H., Karkkainen P., Karvonen A.L., Nurmi H., and Niemela O. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver Int. 28 (2008) 787-797